Angiotensin-converting enzyme (ACE) and aldosterone concentration were measured in the plasma of 32 pregnant women with normal blood pressure or with pregnancy-induced hypertension (PIH). Mean arterial pressure (MAP) in PIH women was significantly higher than in normotensive pregnant women. Plasma ACE activity and aldosterone concentration in 17 PIH patients was significantly lower than their normotensive counterparts
Introduction
Pregnancy may be complicated by elevated blood pressure or may exacerbate pre-existing hypertension. The mechanism that underlies pregnancyinduced hypertension (PIH) is unknown and it is possible that the rise in blood pressure is a manifestation of more than one pathologic condition.
1,2 It has been reported that women with PIH have a more pronounced response to the potent vasoconstrictor angiotensin II (ANG II) relative to normotensive pregnant women. 3 This enhanced sensitivity to ANG precedes the development of high blood pressure and may reflect mechanisms that are in part responsible for the resulting PIH. 4, 5 However, current data suggest that after PIH is established, therapeutic use of an ANG antagonist does not reduce blood pressure. 6 In the normal pregnant state, there is an increase in circulating levels, in plasma renin activity (PRA), ANG II and aldosterone. 7 At the same time vascular ANG II sensitivity is greatly reduced, as early as 14 weeks of gestation. 8 In women in whom PIH developed, there is a reduction in ANG II sensitivity early in pregnancy, but this reduction is lost after 22 weeks of gestation and predates the development of PIH. 3 At the same time vascular sensitivity is greatly increased, associated with increased ANG II binding in platelets 9 which have been found to mirror changes in the vascular ANG II receptor. In addition, several studies have documented significantly lower PRA, ANG II and aldosterone levels in women with PIH, compared with those in their normotensive counterparts, 9 suggesting that an increase in receptor number in target organs may reflect ANG II receptor upregulation by circulating ANG II. Whether these changes observed in women who develop PIH are related to factors that control ANG II synthesis or degradation, or to other factors, is not well established. In regard to ANG II synthesis the data are controversial. Several studies reported that the level of serum angiotensin-converting enzyme (ACE) activity in PIH patients was higher than that in normotensive pregnant women. [10] [11] [12] Another failed to find any difference in ACE activity between them. 13 Contrary to these results, we hypothesize that if plasma ANG II levels, plasma renin substrate and plasma renin concentration are all decreased in the third trimester in women with pregnancyinduced hypertension, it is likely that ANG II biosynthesis (ACE activity) also be altered in the same direction. To clarify this controversy, we measured two of the components of the reninangiotensin-aldosterone system (RAA system): plasma ACE activity and plasma aldosterone concentration in third trimester women with PIH and those without PIH.
Materials and methods

Subjects
Seventeen PIH patients and 15 normotensive pregnant women without oedema or proteinuria (all in the third trimester), aged from 19 to 35 years, were chosen from out-patients in the prenatal service of "Jesú s Yerena Lídice" Hospital. None of them had a history of renal or hepatic diseases, diabetes mellitus, chronic hypertension or antihypertensive treatment. Patients with pre-eclampsia were selected on the basis of the following criteria: blood pressure 140/90 mm Hg or greater, proteinuria defined as 300 mg or more of urinary protein during a 24-h period without any renal disease or urinary tract infection, and normal blood pressure when first seen and after delivery. All patients with PIH deliv-S37 ered at Ͼ34 weeks. All patients gave informed consent. Table 1 summarises the most relevant clinical characteristics of the patients.
Assays
Plasma ACE activity was assayed in duplicated 10 l aliquots by means of the radiometric method described by Rohrbach 14 and modified by Israel et al, 15 with 1.33 mM of Hippuryl-His-Leu-(1-14 C)glycine (HHL) (2.9 Ci/mol, New England Nuclear, Boston, MA, USA) as substrate. Briefly, each woman rested for 30 min in the left lateral position before 10 ml blood were withdrawn from an antecubital vein in the right arm and collected in tubes containing heparin (20 l/blood ml) on ice. Plasma was separated by centrifugation for 10 min (10 000 rpm) and stored at −4°C. Assay was performed within 1 week. After the sample was incubated with substrate (HHL) at 37°C for 60 min, the reaction was terminated by acidification (HCl). Generated hippuric acid (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) C) was extracted with ethyl acetate, desiccated and counted with scintillation spectrometry. ACE activity is expressed in nmol of product formed per hour per plasma mililitre (nmol/hr/ml).
Plasma aldosterone concentration was measured by solid-phase radioimmunoassay (RAI) from Aldosterone-Coat-A Count ® (Diagnostic Products, Los Angeles, CA, USA). Plasma aldosterone concentration was expressed as pg/ml.
Mean arterial pressure (MAP) was measured with a vertical mercury sphygmomanometer. The point of muffling was used to obtain the diastolic blood pressure. MAP was calculated = diastolic blood pressure + 1/3 (systolic blood pressure-diastolic blood pressure).
Statistical analysis
Data are presented as means ± s.e.m. Significance between groups was determined using the Student's t-test and linear regression analysis as appropriate. A P value Ͻ0.05 was considered statistically significant.
Results
The clinical characteristics of the patient groups are shown in Table 1 . There was no significant difference between groups with respect to age and gestational age. Mean blood pressure was significatively higher in patients with PIH compared with pregnant normotensive subjects.
Plasma ACE activity (expressed in nmol/h/ml) in 
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PIH patients (218.88 ± 31) was lower than in normotensive pregnant women (482.73 ± 67) (P Ͻ 0.0001). Plasma aldosterone concentration (expressed in pg/ml) was also reduced in PIH subjects (82 ± 25) when compared to normotensive pregnant women (223 ± 60) (P Ͻ 0.0001) ( Figure 1 ). As shown in Figures 2 and 3 , in all 32 pregnant woman, MAP showed a significant negative correlation with the levels of plasma ACE activity (y = −3.8x + 194; r = −0.04368, P = 0.01) and with plasma aldosterone concentration (y = −1.599x + 199, r = 0.367, P Ͻ 0.005).
Discussion
The cause of altered ANG II sensitivity in women with PIH is unknown. There is considerable evidence to support the hypothesis of an inadequate synthesis of vasodilator eicosanoids in such patients; possible mechanisms involving altered synthesis and/or metabolism of other vasoactive compounds have also been proposed. ACE is a key enzyme in the regulation of the synthesis of vasoconstrictor ANG II, and in the inactivation of vasodilator bradykinin. In turn, bradykinin regulates PGI2 and PGE2 production. 16 Thus, major interest was found in measuring plasma ACE activity in normal and pregnancy-induced hypertension with the aim of investigating further mechanisms responsible for the gestational elevation of blood pressure.
Our present results demonstrate that plasma ACE activity and plasma aldosterone concentration are markedly reduced in PIH patients compared with that in normotensive pregnant women, suggesting that pregnancy-induced hypertension is biochemically characterised by suppression of the circulating components of the renin-angiotensin-aldosterone system, as reflected by a decrease in plasma ACE activity and plasma aldosterone concentration. In agreement with our results, several previous studies have documented significantly lower plasma renin activity, ANG II and aldosterone levels in women with PIH compared with those in their normotensive counterparts. 9 Recently it has been suggested that PIH is characterised by imbalances in the production rates of several arachidonic acid metabolites. Thus, a reduced plasma ACE activity may be associated with the imbalance of the vasoconstrictor and vasodilator systems in PIH, and possibly accounts for the clinical symptoms of PIH. Furthermore, suppression of ANG II synthesis and bradykinin metabolism may contribute to increased ANG II receptor sites on target cells and thus the enhanced vascular sensitivity to exogenous ANG II seen in women with PIH. In effect, characterisation of the interaction of ANG II with its platelet receptor in women with PIH have shown significantly higher specific binding of ANG II to its receptor than third trimester normotensive women. 9 Previously, studies have suggested that the ANG II receptor on platelet is regulated by ANG II in parallel with the receptor in the vasculature. 8 It is known that vascular smooth muscle ANG II receptor numbers change inversely with circulating ANG II concentrations. In consequence, a reduced biosynthetic ECA activity (present results), and thus a reduced plasma ANG II, may cause a feedback 'upregulation' of ANG II receptor number, as found in women with PIH. Further, the reduced ECA activity in PIH could be related to the lack of therapeutic effect of ACE inhibitors in the treatment of PIH. 6 Our findings do not support those of others who reported that the level of serum ACE activity in PIH patients was higher 10, 12, 17 or not altered 13 when compared with those in normotensive pregnant women. This may reflect differences in gestational age, antihypertensive treatment and the method of determination. In our study, ECA activity was assessed in plasma samples using a highly sensitive radiometric method, while others have used serum as sample and colorimetric methods. Our data show a negative and significant correlation between MAP and plasma ACE activity, or MAP and plasma aldosterone concentration, indicating that the extent to which ANG II synthesis is suppressed in pregnancyinduced hypertension correlates strongly with the alteration in blood pressure.
In conclusion, this study demonstrated reduced plasma ECA activity and aldosterone concentration in PIH subjects when compared with normotensive pregnant women. The mechanism of alteration in the regulation of ACE activity in PIH is unclear. However, the possibility that deficient ACE activity may account for altered regulation of blood pressure in pre-eclampsia merits further study and validation.
